(Q64140085)
Statements
A Phase 1b, Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Single Ascending Dose Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of DS-1040b When Added to Standard of Care Anticoagulation Therapy in Subjects With Acute Submassive Pulmonary Embolism (English)
0 references
23 June 2016
0 references
31 August 2019
0 references
137
0 references
18 year
0 references
75 year
0 references